BRCA1に関連したBARD1とポリアデニレーション因子CstF-50の機能的相互作用
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Science (New York, N.Y.)
|September 8, 1999
まとめ
BRCA1関連RINGドメインタンパク質 (BARD1) は,主要なポリアデニレーション因子 (CstF-50) と相互作用し,RNA処理を抑制する. この発見は,DNA修復と遺伝子発現の調節の間の新しいリンクを明らかにしています.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝子発現の規制について
- RNA 処理 RNA 処理
背景:
- メッセンジャーRNA (mRNA) 処理,特にポリアデニレーションは,遺伝子発現に不可欠であり,複雑なタンパク質機構が含まれています.
- この機械は,RNA合成中の転写装置と密接に結びついています.
研究 の 目的:
- BRCA1に関連したRINGドメインタンパク質 (BARD1) の機能を調査するために,これまで知られていなかった役割を持つ核タンパク質.
- BARD1とmRNAポリアデニレーション機構の構成要素との潜在的な相互作用を探求する.
主な方法:
- BARD1とCstF-50のタンパク質結合をテストするためのインビトロ相互作用アッセイ.
- BARD1-CstF-50の相互作用を確認するために,無傷の細胞を用いた細胞ベースの測定法.
- RNAポリメラーゼIIの相互作用に関する研究.
主要な成果:
- BARD1は,重要なポリアデニレーション因子であるCstF-50 (分裂刺激因子) と相互作用することが判明しました.
- BARD1とCstF-50の相互作用は,ポリアデニレーションを in vitro で抑制することが示されました.
- BARD1とCstF-50の両方がRNAポリメラーゼIIと相互作用することが観察されました.
結論:
- BARD1媒介によるポリアデニレーションの阻害は,転写中の異常なRNA処理を防ぐために役立つ可能性があり,潜在的にDNA修復部位にあります.
- これらの発見は,DNA修復経路とRNA処理イベントの間の予期せぬ統合を明らかにしています.
- この研究は,BARD1を転写,RNA処理,DNA修復を結びつける新しいレギュレータとして特定しています.
関連する概念動画
01:57Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...